|
related topics |
{stock, price, share} |
{product, liability, claim} |
{product, candidate, development} |
{stock, price, operating} |
{acquisition, growth, future} |
{property, intellectual, protect} |
{personnel, key, retain} |
{competitive, industry, competition} |
|
Risks Related To Our Proposed Business
We are an early-stage company subject to all of the risks and uncertainties of a new business.
We have had no product sales to date, and we can give no assurance that there will ever be any sales in the future.
There is no guarantee that our products will be accepted by consumers.
We will need significant additional capital, without which we will have to curtail or cease operations.
We are dependent on key personnel
We will be subject to competition from numerous companies, including a number of multi-national companies, that have significantly greater financial and other resources
We will have to rely on third parties to manufacture our products who may not perform to our standards or timeline.
We have not yet entered into any agreements with purchasers of our products
We have no patent protection and may not be able to protect our proprietary rights.
We may be subject to product liability claims.
Risks Related To Our Common Stock
Our stock is thinly traded, so you may be unable to sell your shares at or near the quoted bid prices if you need to sell a significant number of your shares.
You may have difficulty selling our shares because they are deemed penny stocks .
Potential issuance of additional common stock could dilute existing stockholders.
Our existing directors, officers and key employees hold a substantial amount of our common stock and may be able to prevent other stockholders from influencing significant corporate decisions.
The market price of our stock may be adversely affected by market volatility.
Full 10-K form ▸
|
|
related documents |
3116--3/30/2006--AKORN_INC |
826253--6/15/2009--AURA_SYSTEMS_INC |
3116--3/16/2007--AKORN_INC |
1042610--10/13/2010--TRB_SYSTEMS_INTERNATIONAL_INC |
1042610--10/13/2009--TRB_SYSTEMS_INTERNATIONAL_INC |
826253--6/13/2008--AURA_SYSTEMS_INC |
3116--3/16/2010--AKORN_INC |
1079028--11/26/2008--VARIAN_INC |
1372507--4/15/2009--RAVEN_BIOFUELS_INTERNATIONAL_CORP |
826253--3/25/2008--AURA_SYSTEMS_INC |
1059784--10/16/2006--GENEREX_BIOTECHNOLOGY_CORP |
826253--3/25/2008--AURA_SYSTEMS_INC |
1091356--3/31/2008--SEAENA_INC. |
1371128--3/25/2008--BioSolar_Inc |
1011733--4/15/2009--TRIMOL_GROUP_INC |
1144225--4/12/2010--instaCare_Corp. |
1144225--5/18/2009--instaCare_Corp. |
724910--5/25/2007--NVE_CORP_/NEW/ |
75439--3/31/2009--CytoCore_Inc |
849636--3/15/2007--CORTEX_PHARMACEUTICALS_INC/DE/ |
1121827--3/6/2009--BIG_SKY_INDUSTRIES_VI_INC |
1121827--3/6/2009--BIG_SKY_INDUSTRIES_VI_INC |
1121827--3/4/2009--BIG_SKY_INDUSTRIES_VI_INC |
1121827--2/25/2009--BIG_SKY_INDUSTRIES_VI_INC |
1121827--2/25/2009--BIG_SKY_INDUSTRIES_VI_INC |
1121816--2/20/2009--BIG_SKY_INDUSTRIES_V_INC |
1121816--2/18/2009--BIG_SKY_INDUSTRIES_V_INC |
1121816--2/18/2009--BIG_SKY_INDUSTRIES_V_INC |
1121816--2/13/2009--BIG_SKY_INDUSTRIES_V_INC |
1121816--2/13/2009--BIG_SKY_INDUSTRIES_V_INC |
|